彭柔君
专长
一、基本情况
综合科主诊教授，周一上午、周四下午门诊。
二、教育及工作经历
2000年毕业于中山医科大学临床医学系，获学士学位
2007年毕业于中山大学，获肿瘤学硕士学位
2011年毕业于中山大学，获肿瘤学博士学位
2008年至2010年留学瑞典卡罗林斯卡医学院，中-瑞联合培养博士研究生
2000年7月至2015年7月，中山大学肿瘤防治中心内科，从事恶性肿瘤内科治疗，住院医师、主治医师及副主任医师
2015年8月至今，中山大学肿瘤防治中心综合科，从事恶性肿瘤综合治疗，副主任医师、主任医师
2016年1月起聘任为中山大学硕士研究生导师、博士研究生导师
三、学术兼职
广东省精准医学应用学会肿瘤综合治疗分会第一届委员会主任委员
广东省医学会肿瘤精准诊疗分会第一届常务委员
广东省药学会妇科肿瘤专家委员会常务委员
广东省健康管理学会妇科肿瘤多学科协作专业委员会常务委员
广东省健康管理学会委员常务委员
胸部肿瘤防治研究会乳腺癌专业委员会第一届委员会常务委员
广东省中西医结合学会乳腺病专业委员会第一届委员会常务委员
华南乳腺癌临床研究协作组第一届委员会秘书
吴阶平基金会营养学部中西医结合营养专业委员会第一届常务委员
四、主持科研项目
国家自然科学基金面上项目、国家自然科学基金青年基金项目、广东省自然科学面上项目、广州市科技市科技计划项目、中山大学高校基本科研业务青年教师重点培育项目、吴阶平医学基金会临床研究专项基金、中国抗癌协会横向联系基金、广东省药学会横向联系基金、中山大学肿瘤防治中心回国人员科研启动基金等。
五、代表性论著
1. Yi-Qi Li, Chun-Ling Luo, Jia-Xin Jiang, Shuai He, Yang Liu, Wen-Xin Yan, Yi Xia, Qian Cui, Ying Huang, Jing Quan Lim, Dachuan Huang, Izzah Nabilah Hussein, Yan Gao, Guo-Wang Lin, Yi-Hong Ling, Dong Ma, Yue-Tong Zhang, Jason Yongsheng Chan, Pan-Pan Wei, Xiao-Xiao Wang, Chee Leong Cheng, Jie Xiong, Wei-Li Zhao, Choon Kiat Ong, Soon Thye Lim, Hui-Qiang Huang, Rou-Jun Peng*, and Jin-Xin Bei*. Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma. Adv Sci (Weinh). 2023 Dec;10(36): e2303913.
2. Zhaohui Ruan#, Yuetong Zhang#, Zhaozhi Li#, Jiaxin Jiang, Wei Luo, Qi Quan, Zihao Xu, Jinju Lei*, Roujun Peng*. Characteristics and classification of first primary cancer patients with second primary cancer: a population-based cohort study. Clin Exp Med. 2023 Aug 9. doi: 10.1007/s10238-023-01149-3.
3. Zhaohui Ruan#, Qi Quan#, Qianyu Wang#, Jiaxin Jiang, Roujun Peng*. New Staging System and Prognostic Model for Malignant Phyllodes Tumor Patients without Distant Metastasis: A Development and Validation Study. J. Clin. Med. 2023, 12(5), 1889.
4. Wei Luo#, Qi Quan#, Jiaxin Jiang, Roujun Peng*. An immune and epithelial-mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas. Front Genet. 2023 Jan 4;13:1070630.
5. Zhaohui Ruan # , Dongmei Chi # , Qianyu Wang , Jiaxin Jiang , Qi Quan , Jinxin Bei , Roujun Peng*. Development and validation of a prognostic model and gene co-expression networks for breast carcinoma based on scRNA-seq and bulk-seq data. Ann Transl Med. 2022 Dec;10(24):1333.
6. Zhaohui Ruan#, Yuetong Zhang#, Qi Quan , Jiaxin Jiang, Qianyu Wang, Yujing Zhang*, Roujun Peng*. Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity. Front Genet. 2022 Dec 7;13:1004467.
7. Qianyu Wang# , Guifang Guo#, Zhaohui Ruan , Huijiao Cao, Ying Guo , Long Bai , Chang Jiang, Shousheng Liu, Wenzhuo He , Jinsheng Huang , Yuming Rong , Xuxian Chen, Liangping Xia , Bei Zhang* , Roujun Peng*. Safety and Efficacy of Long-Term Zoledronic Acid in Advanced Breast Cancer with Bone Metastasis in South China. J Oncol. 2020 Sep 30;2020:5670601.
8. Roujun Peng#, Bowei Han#, Qingqing Cai#, Xiaoyu Zuo, Tao Xia, Jierong Chen, Lina Feng, Jingquan Lim, Shuwei Chen, Musheng Zeng, Yunmiao Guo, Bo Li, Xiaojun Xia, Yi Xia, Yurike Laurensia, Burton Kuan Hui Chia, Huiqiang Huang, Ken He Young, Soon Thye Lim, Choon Kiat Ong*, Yixin Zeng*, Jinxin Bei*; Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma. Leukemia, 2019, 33(6):1451-1462.
9. Haohua Wang#, Roujun Peng#, Xiuxing Chen, Rui Jia, Chunyue Huang, Yuanyuan Huang, Liangping Xia, Guifang Guo. Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer. Oncol Lett. 2018 Apr;15(4):5553-5560.
10. Weicheng Ren#, Xiaofei Ye#, Hong Su, Wei Li, Dongbing Liu, Mohammad Pirmoradian, Xianhuo Wang, Bo Zhang, Qiang Zhang, Longyun Chen, Man Nie, Yao Liu, Bin Meng, Huiqiang Huang, Wenqi Jiang, Yixin Zeng, Wenyu Li, Kui Wu, Yong Hou, Klas G Wiman, Zhiming Li, Huilai Zhang, Roujun Peng#, Shida Zhu#, Qiang Pan-Hammarström#. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma. Blood. 2018, 131:2670-2681.
11. Zheng Li#, Yi Xia#, Li-Na Feng, Jie-Rong Chen, Hong-Min Li, Jing Cui, Qing-Qing Cai, Kar Seng Sim, Maarja-Liisa Nairismägi, Yurike Laurensia, Wee Yang Meah, Wen-Sheng Liu, Yun-Miao Guo, Li-Zhen Chen, Qi-Sheng Feng, Chi Pui Pang, Li Jia Chen, Soo Hong Chew, Richard P Ebstein, Jia Nee Foo, Jianjun Liu, Jeslin Ha, Lay Poh Khoo, Suk Teng Chin, Yi-Xin Zeng, Tin Aung, Balram Chowbay, Colin Phipps Diong, Fen Zhang, Yan-Hui Liu, Tiffany Tang, Miriam Tao, Richard Quek, Farid Mohamad, Soo Yong Tan, Bin Tean Teh, Siok Bian Ng, Wee Joo Chng, Choon Kiat Ong, Yukinori Okada, Soumya Raychaudhuri, Soon Thye Lim, Wen Tan, Rou-Jun Peng*, Chiea Chuen Khor*, Jin-Xin Bei*. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study. Lancet Oncol. 2016 Sep;17(9):1240-7.
12. Konstantinos Georgiou#, Longyun Chen#, Mattias Berglund, Weicheng Ren, Noel F C C de Miranda, Susana Lisboa, Marco Fangazio, Shida Zhu, Yong Hou, Kui Wu, Wenfeng Fang, Xianhuo Wang, Bin Meng, Li Zhang, Yixin Zeng, Govind Bhagat, Magnus Nordenskjöld, Christer Sundström, Gunilla Enblad, Riccardo Dalla-Favera, Huilai Zhang, Manuel R Teixeira, Laura Pasqualucci, Roujun Peng*, Qiang Pan-Hammarström*. Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas. Blood. 2016 Jun 16;127(24):3026-34.
13. Cong Xue#, Roujun Peng#, Ye Cao, Shusen Wang, Yanxia Shi, Xin An, Fei Xu, Zhongyu Yuan*. Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer. PLoS One. 2016 Feb 11;11(2):e0148849.
14. de Miranda NF, Georgiou K, Chen L, Wu C, Gao Z, Zaravinos A, Lisboa S, Enblad G, Teixeira MR, Zeng Y, Peng R*, Pan-Hammarström Q. Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients. Blood. 2014. 124(16):2544-53.
15. de Miranda NF, Peng R#, Georgiou K, Wu C, Falk Sörqvist E, Berglund M, Chen L, Gao Z, Lagerstedt K, Lisboa S, Roos F, van Wezel T, Teixeira MR, Rosenquist R, Sundström C, Enblad G, Nilsson M, Zeng Y, Kipling D, Pan-Hammarström Q. DNA repair genes are selectively mutated in diffuse large B cell lymphomas. J Exp Med. 2013. 210: 1729-42.
16. Du L, Peng RJ#, Bjorkman A, Filipe de Miranda N, Rosner C, Kotnis A, Berglund M, Liu C, Rosenquist R, Enblad G, Sundstrom C, Hojjat-Farsangi M, Rabbani H, Teixeira MR, Revy P, Durandy A, Zeng Y, Gennery AR, de Villartay JP, Pan-Hammarstrom Q. Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis. J Exp Med. 2012.209: 291-305.
17. Peng RJ#, Huang ZF, Zhang YL, Yuan ZY, Xia Y, Jiang WQ, Zeng YX, Li J. 2011. Circulating and tumor-infiltrating Foxp3(+) regulatory T cell subset in Chinese patients with extranodal NK/T cell lymphoma. Int J Biol Sci 7: 1027-36.
18. Peng RJ#, Wang S, Shi Y, Liu D, Teng X, Qin T, Zeng Y, Yuan Z. 2011. Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: a retrospective matched case-control study. Breast 20: 568-73.
更新时间：2024.06.07
